Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Joanne Luider, Karen A. Kopciuk, Yuan Dong, Ahmed A. Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C. Chin, Matt C. Coffey, Victor H. Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P. Leif Bergsagel, Don Morris

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model'. Together they form a unique fingerprint.

Medicine & Life Sciences